Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807091 · ClinicalTrials.gov registry record · NA
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01807091 is a NA study that has completed, run by University of Washington. The registered enrollment target is 17 participants.
The verdict
NCT01807091, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This pilot clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or advanced myelodysplastic syndrome (MDS), at least 18 years of age will be examined. Treating eligible patients with induction chemotherapy in an outpatient setting may save in healthcare cost and improve a patients' quality of life.
Interventions
- DRUG Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-05-21 |
| Est. Completion | 2020-01-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01807091
The ClinicalTrials.gov registry entry for NCT01807091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chemotherapy is the first listed.
NCT01807091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01807091 about?
NCT01807091 is a clinical study titled "Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome". This pilot clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or advanced myelodysplastic syndrome (MDS), at least 18 years of age will be examined. Treating eligible patients with induction chemotherapy in an outpatie...
What is the current status of trial NCT01807091?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2013-05-21. Estimated completion is 2020-01-08.
What interventions are being tested in trial NCT01807091?
The interventions under investigation include: Chemotherapy (DRUG).
Who is sponsoring clinical trial NCT01807091?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.